Home
/
Conditions
/ Thyroid Nodules
Thyroid Health
Schedule a Consultation
Thyroid Nodules
Thyroid nodules are solid or fluid-filled growths within the thyroid gland that are present in up to 65 percent of the adult population when screened by ultrasound. The vast majority are benign, but their presence signals an underlying thyroid environment that deserves evaluation beyond the nodule itself. Conventional management monitors nodule size and biopsies suspicious lesions. Functional medicine asks what produced the nodule formation in the first place: iodine dysregulation, selenium deficiency, autoimmune thyroiditis, insulin resistance, and environmental toxin exposure are among the most consistently identified and most treatable upstream drivers.
Thyroid HealthRoot Cause MedicineEvaluable
Up to 65%of adults have thyroid nodules detectable on ultrasound
~5%of thyroid nodules are malignant; the vast majority are benign
Addressablewhen the thyroid environment producing nodule formation is identified
← Back to Conditions
Condition: Thyroid Nodules | Category: Thyroid Health | Reviewed by: Brian Lamkin, DO
What Are Thyroid Nodules?
Thyroid nodules are discrete growths of thyroid tissue within the gland that form solid, cystic, or mixed-composition lesions. They are extraordinarily common; ultrasound screening detects nodules in up to 65 percent of the adult population, with prevalence increasing with age. The overwhelming majority are benign follicular adenomas, colloid nodules, or cystic lesions. Approximately 5 percent of clinically detected nodules are malignant, most commonly papillary thyroid carcinoma, which has an excellent prognosis when identified.
The conventional approach to thyroid nodules is straightforward: characterize by ultrasound, risk-stratify using TI-RADS (Thyroid Imaging Reporting and Data System), biopsy when indicated, and monitor over time. This approach appropriately addresses malignancy risk but does not ask the more fundamental question: why is this thyroid producing nodules? The thyroid gland does not form nodules randomly. Nodular transformation is the result of a specific microenvironment of nutrient imbalance, autoimmune inflammation, hormonal stimulation, and metabolic dysfunction that is identifiable and in many cases modifiable.
Key principle: A thyroid nodule is a signal, not just a lesion. It tells you that the thyroid microenvironment has shifted toward proliferative growth. Evaluating and addressing that environment, through nutrient optimization, autoimmune modulation, and metabolic intervention, is complementary to the standard monitoring approach and may influence nodule behavior over time.
Why It Matters
Clinical Significance
- Approximately 5 percent of nodules are malignant, requiring proper risk stratification through ultrasound characteristics and fine needle aspiration when indicated
- Nodules can produce autonomous thyroid hormone (toxic adenoma), causing subclinical or overt hyperthyroidism independent of TSH regulation
- Large nodules can cause compressive symptoms including difficulty swallowing, voice changes, or a visible neck mass
- Thyroid nodules coexist with Hashimoto's thyroiditis at elevated rates, and the autoimmune inflammatory environment both promotes nodule formation and independently requires treatment
What Standard Monitoring Misses
- The thyroid environment is not evaluated: iodine status, selenium, TPO and thyroglobulin antibodies, and metabolic markers are not part of the standard nodule monitoring protocol
- Autoimmune thyroiditis is frequently present but not assessed unless TSH is already abnormal; the autoimmune process contributes to both nodule formation and thyroid functional decline
- Insulin resistance and IGF-1 are independent growth factors for thyroid tissue proliferation but are not measured in standard endocrine nodule evaluation
- Serial monitoring documents nodule behavior without intervening in the thyroid environment that is producing and sustaining the nodular growth
Common Symptoms
Nodule-Specific
- Most nodules are asymptomatic and discovered incidentally on imaging
- Palpable neck mass or visible thyroid enlargement
- Difficulty swallowing or sensation of pressure in the throat
- Voice hoarseness if the nodule compresses the recurrent laryngeal nerve
Thyroid Dysfunction
- Hyperthyroid symptoms if the nodule is autonomously producing hormone: palpitations, weight loss, anxiety, heat intolerance
- Hypothyroid symptoms if concurrent Hashimoto's is present: fatigue, weight gain, cold intolerance, cognitive slowing
- Fluctuating thyroid symptoms in Hashimoto's with nodular transformation
- No thyroid symptoms in many patients with incidental small nodules
Associated Findings
- Elevated thyroid antibodies indicating concurrent autoimmune thyroiditis
- Elevated TSH providing ongoing growth stimulus to the nodule
- Selenium or iodine deficiency identified on nutritional testing
- Family history of thyroid nodules or thyroid cancer
Root Causes: A Functional Medicine Perspective
Conventional endocrinology characterizes and monitors thyroid nodules. Functional medicine evaluates the thyroid microenvironment that produces them.
Iodine Dysregulation
Iodine is the essential substrate for thyroid hormone synthesis. Both deficiency and excess can promote nodule formation. Iodine deficiency increases TSH, which is a direct growth factor for thyroid follicular cells, promoting compensatory hyperplasia and nodular transformation. Excessive iodine supplementation in the context of existing autoimmune thyroiditis can worsen thyroid inflammation and oxidative damage. Proper assessment of iodine status is essential before supplementation.
Autoimmune Thyroiditis
Hashimoto's thyroiditis creates a chronic inflammatory microenvironment within the thyroid gland characterized by lymphocytic infiltration, oxidative stress, and cycles of tissue destruction and regeneration. This inflammatory milieu promotes the formation of both benign nodules and, in rare cases, thyroid lymphoma. TPO and thyroglobulin antibodies identify this autoimmune contribution. Selenium supplementation reduces TPO antibodies and thyroid oxidative stress in Hashimoto's patients.
Selenium Deficiency and Oxidative Stress
Selenium is a cofactor for glutathione peroxidase, the primary antioxidant enzyme in thyroid tissue. The thyroid produces more hydrogen peroxide per gram than any other organ during hormone synthesis, and selenium-dependent glutathione peroxidase is the protective mechanism that prevents oxidative damage from this metabolic byproduct. Selenium deficiency leaves thyroid tissue vulnerable to oxidative injury, promoting inflammation and nodular transformation.
Insulin Resistance and Metabolic Stimulation
Insulin resistance and elevated IGF-1 are independent growth factors for thyroid tissue. Metabolic syndrome is associated with increased thyroid nodule prevalence and increased nodule size. Elevated fasting insulin promotes thyroid cell proliferation through the insulin receptor and IGF-1 receptor pathways. Metabolic optimization reduces this proliferative stimulus.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Evaluation | Ultrasound, TI-RADS scoring, FNA biopsy when indicated; TSH | All standard assessment plus TPO/thyroglobulin antibodies, selenium, iodine status, fasting insulin, full thyroid panel |
| Management | Serial ultrasound monitoring; surgery or radioactive iodine for concerning or autonomous nodules | Standard monitoring plus thyroid microenvironment optimization: selenium, iodine assessment, autoimmune modulation, metabolic intervention |
| Root cause | Not evaluated; nodules treated as isolated structural findings | Nutrient deficiency, autoimmune contribution, metabolic growth stimulus, and environmental factors assessed as modifiable drivers |
| Goal | Rule out malignancy; monitor size stability | Rule out malignancy and modify the thyroid environment promoting nodule formation and growth |
Key Labs to Evaluate
Thyroid nodule evaluation in a functional medicine framework extends beyond TSH to assess the thyroid environment producing the nodular transformation.
TSHElevated TSH is a direct growth stimulus for thyroid follicular cells promoting nodule formation.
→TPO AntibodiesIdentifies autoimmune thyroiditis creating the inflammatory nodule-promoting microenvironment.
→SeleniumEssential antioxidant cofactor protecting thyroid tissue from oxidative damage.
→Free T3Active thyroid hormone. Low free T3 confirms functional thyroid insufficiency beyond TSH.
→Fasting InsulinInsulin and IGF-1 are independent growth factors for thyroid tissue proliferation.
→How to Interpret These Labs Together
Elevated TSH with positive TPO antibodies and low selenium identifies the autoimmune-nutrient-deficient thyroid environment that is most strongly associated with nodule formation. The elevated TSH provides the growth stimulus, the autoimmune inflammation promotes dysregulated tissue remodeling, and the selenium deficiency removes the antioxidant protection that would normally limit oxidative damage.
Normal TSH with elevated fasting insulin and positive antibodies identifies the metabolic-autoimmune pattern in which insulin-driven and IGF-1-driven proliferative signaling operates alongside autoimmune inflammation to promote nodular growth even when TSH is not elevated.
Suppressed TSH with a solitary nodule suggests an autonomous (hot) nodule producing thyroid hormone independently of pituitary regulation. This requires thyroid scintigraphy to confirm autonomy and guides the decision between monitoring, radioactive iodine, or surgical intervention.
Common Patterns Seen in Patients
- The incidental nodule with "normal labs": A 1.2 cm nodule found on carotid ultrasound. TSH 2.8, told thyroid is fine. Extended panel: TPO antibodies 194, selenium low at 92 mcg/L, vitamin D 24. Early Hashimoto's with selenium deficiency in a thyroid environment actively promoting nodule formation. Selenium supplementation, vitamin D repletion, and thyroid optimization to reduce TSH growth stimulus.
- The growing nodule despite "stable" monitoring: Nodule increasing from 1.0 to 1.8 cm over 3 years. TSH 4.2 throughout that period, providing continuous growth stimulus. Thyroid optimization to reduce TSH to 1.5 removed the proliferative signal; nodule growth stabilized on subsequent imaging.
- Multiple nodules in a patient with metabolic syndrome: Four nodules identified on ultrasound. Fasting insulin 19, BMI 34, triglycerides elevated. Insulin-driven and IGF-1-driven thyroid tissue proliferation operating alongside elevated TSH. Metabolic intervention targeting insulin resistance reduced the proliferative stimulus to the thyroid.
- The anxious patient told to "just watch": Single 8mm nodule. Benign appearance on ultrasound. Told to repeat imaging in 12 months. No lab evaluation beyond TSH. The patient's anxiety about cancer was addressed by proper TI-RADS scoring (benign features), and the functional evaluation identified Hashimoto's with selenium deficiency as the treatable thyroid environment producing the nodule.
Treatment and Optimization Strategy
Thyroid Microenvironment Modification
Functional medicine treatment of thyroid nodules does not replace standard risk assessment and monitoring. It adds a layer of intervention targeting the thyroid environment that produces and sustains nodular growth.
Nutrient and Autoimmune Interventions
- Selenium supplementation (200 mcg daily as selenomethionine) to restore glutathione peroxidase activity and reduce TPO antibodies
- Iodine status assessment before any supplementation; iodine excess in Hashimoto's can worsen thyroid inflammation
- Vitamin D optimization to 60 to 80 ng/mL for immune modulation and thyroid autoimmune management
- Autoimmune modulation through gut permeability repair, gluten evaluation, and anti-inflammatory protocols when Hashimoto's is present
Thyroid and Metabolic Optimization
- TSH optimization to 1.0 to 2.0 to reduce the growth stimulus driving nodule formation, when clinically appropriate
- Insulin sensitization when metabolic syndrome or elevated fasting insulin is identified as a proliferative driver
- Environmental toxin assessment: perchlorate, fluoride, and bromide compete with iodine for thyroid uptake and may contribute to nodular transformation
- Oxidative stress reduction through antioxidant support (CoQ10, NAC) and dietary anti-inflammatory protocols
What Most Doctors Miss
- The thyroid environment is not evaluated: standard nodule management assesses the nodule but not the gland producing it. Selenium, iodine status, autoimmune markers, and metabolic drivers are not part of the monitoring protocol.
- Autoimmune thyroiditis is underdiagnosed: TPO and thyroglobulin antibodies are not tested unless TSH is already abnormal. Hashimoto's is a primary contributor to nodule formation and can be active with a normal TSH for years.
- TSH as a growth stimulus is not addressed: a TSH of 4.0 is classified as normal but provides continuous proliferative signaling to thyroid tissue. Optimizing TSH to 1.0 to 2.0 reduces this growth drive.
- Insulin resistance as a thyroid proliferator is not recognized: metabolic syndrome is independently associated with increased thyroid nodule prevalence, yet fasting insulin and metabolic assessment are never part of thyroid nodule evaluation.
When to Seek Medical Care
If you have been told you have a thyroid nodule, a palpable lump in your neck, difficulty swallowing, or voice changes, proper evaluation including thyroid ultrasound with TI-RADS scoring is warranted. If you have a known thyroid nodule being monitored with serial ultrasound alone, a comprehensive thyroid evaluation including autoimmune markers, nutrient status, and metabolic assessment can identify modifiable drivers of nodule formation that standard monitoring does not address.
At The Lamkin Clinic, thyroid nodule evaluation includes standard risk assessment plus a full thyroid panel (TSH, free T3, free T4, TPO antibodies, thyroglobulin antibodies), selenium, vitamin D, fasting insulin, and iodine status assessment.
Recommended Testing
Thyroid nodule evaluation in a functional medicine framework extends beyond malignancy risk assessment to evaluate the thyroid environment producing the nodular growth.
Thyroid Panel
- TSH
- Free T3, Free T4
- TPO Antibodies
- Thyroglobulin Antibodies
Microenvironment Assessment
- Selenium
- Vitamin D
- Fasting Insulin
- Iodine (urinary or serum)
Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Are thyroid nodules dangerous?
The vast majority of thyroid nodules are benign. Approximately 5 percent of clinically detected nodules are malignant. Risk assessment is based on ultrasound characteristics and, when indicated, fine needle aspiration biopsy. Even benign nodules signal a thyroid microenvironment that warrants evaluation.
What causes thyroid nodules to form?
The most common drivers include TSH-mediated growth stimulus from iodine deficiency or subclinical hypothyroidism, Hashimoto's thyroiditis creating an inflammatory microenvironment, selenium deficiency reducing antioxidant protection, insulin resistance and elevated IGF-1 stimulating cell proliferation, and environmental toxins competing with iodine for thyroid uptake.
Can thyroid nodules shrink?
Some thyroid nodules can decrease in size when the underlying driver is addressed. Nodules driven by TSH elevation may shrink with thyroid hormone optimization. Nodules in the context of Hashimoto's may stabilize with autoimmune modulation. Cystic nodules may resolve spontaneously. Solid, autonomous nodules are less likely to shrink without procedural intervention.
Should I worry about a thyroid nodule found on imaging?
Most incidentally discovered thyroid nodules are benign. They do warrant proper evaluation including thyroid ultrasound with TI-RADS scoring, a comprehensive thyroid panel, and assessment of the thyroid environment including iodine status, selenium, and metabolic markers.
Does Hashimoto's cause thyroid nodules?
Yes. Hashimoto's thyroiditis is associated with increased thyroid nodule prevalence. The chronic autoimmune inflammation creates a microenvironment of tissue damage, regeneration, and fibrosis that promotes nodular transformation. Autoimmune modulation and thyroid optimization can help stabilize the thyroid environment.
How The Lamkin Clinic Approaches Thyroid Nodules
Clinical Perspective
When a patient comes to me with a thyroid nodule, the first question is always whether it is concerning for malignancy, and we address that with proper ultrasound and risk stratification. But the second question is equally important: why is this thyroid producing nodules? When I test the thyroid environment, I almost always find something modifiable. Hashimoto's with selenium deficiency. An elevated TSH providing growth stimulus. Insulin resistance driving IGF-1-mediated proliferation. These are not just interesting findings; they are treatment targets that can influence nodule behavior over time.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, thyroid nodule evaluation combines standard malignancy risk assessment with comprehensive thyroid environment analysis: full thyroid panel, TPO and thyroglobulin antibodies, selenium, vitamin D, fasting insulin, and iodine status. Treatment is built around modifying the microenvironment that promotes nodule formation while maintaining appropriate imaging surveillance.
Related Conditions
Thyroid DysfunctionComprehensive thyroid evaluation including the functional and autoimmune contributors to nodules
→Hashimoto's ThyroiditisAutoimmune thyroiditis creating the inflammatory microenvironment promoting nodules
→Subclinical HypothyroidismElevated TSH providing continuous proliferative growth stimulus to thyroid tissue
→HypothyroidismThyroid hormone insufficiency frequently coexisting with nodular disease
→Insulin ResistanceMetabolic driver of thyroid cell proliferation through IGF-1 receptor pathways
→Chronic InflammationSystemic inflammation compounding the autoimmune and oxidative thyroid environment
→Related Symptoms
Chronic FatigueConcurrent thyroid dysfunction producing energy depletion alongside nodular disease
→Brain FogLow T3 impairing cognitive function in thyroid disease with nodules
→AnxietyAutonomous nodules producing thyrotoxicosis with anxiety and palpitations
→DyslipidemiaConcurrent hypothyroidism impairing LDL receptor expression and cholesterol clearance
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Thyroid nodules are a signal. Evaluating the thyroid environment is the next step.
The Lamkin Clinic evaluates thyroid nodules with comprehensive thyroid, autoimmune, nutrient, and metabolic assessment beyond standard monitoring. Schedule a consultation for a complete thyroid environment evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.